Adropin levels and its associations as a fat-burning hormone in patients with polycystic ovary syndrome: a correlational meta-analysis.
Sheshadri Reddy VarikasuvuE Prabhakar ReddyBalachandar ThangappazhamSaurabh VarshneyVanita Lal DasManne MunikumarPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)
Adropin levels are significantly reduced in PCOS patients compared to controls, and this decrease was more evident in overweight PCOS patients.
Keyphrases
- skeletal muscle
- insulin resistance
- end stage renal disease
- ejection fraction
- systematic review
- newly diagnosed
- chronic kidney disease
- prognostic factors
- polycystic ovary syndrome
- peritoneal dialysis
- type diabetes
- patient reported outcomes
- randomized controlled trial
- adipose tissue
- body mass index
- fatty acid
- weight loss
- meta analyses